ALPHA TEKNOVA, INC. Selling and Marketing Expense
ALPHA TEKNOVA, INC. (TKNO) reported Selling and Marketing Expense of $2.12 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-06
- ALPHA TEKNOVA, INC. selling and marketing expense for the quarter ending 2026-06-30 was $2.12M, a 34.90% increase year-over-year.
- ALPHA TEKNOVA, INC. selling and marketing expense for the quarter ending 2026-03-31 was $2.13M, a 29.76% increase year-over-year.
- ALPHA TEKNOVA, INC. selling and marketing expense for the quarter ending 2025-12-31 was $1.79M, a 15.22% increase year-over-year.
- ALPHA TEKNOVA, INC. selling and marketing expense for the quarter ending 2025-09-30 was $1.75M, a 6.52% increase year-over-year.
- ALPHA TEKNOVA, INC. selling and marketing expense for fiscal 2025 was $6.75M, a 6.87% increase from fiscal 2024.
- ALPHA TEKNOVA, INC. selling and marketing expense for fiscal 2024 was $6.32M, a 32.26% decline from fiscal 2023.
- ALPHA TEKNOVA, INC. selling and marketing expense for fiscal 2023 was $9.33M, a 1.96% increase from fiscal 2022.
- ALPHA TEKNOVA, INC. selling and marketing expense for fiscal 2022 was $9.15M, a 142.28% increase from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.12M 10-Q · filed 2026-08-06 | $4.25M 10-Q · filed 2026-08-06 | $6.04M derived: sum of 3 quarters · filed 2026-08-06 | $7.79M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.13M 10-Q · filed 2026-05-07 | $3.92M derived: sum of 2 quarters · filed 2026-05-07 | $5.67M derived: sum of 3 quarters · filed 2026-05-07 | $7.24M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $3.54M derived: sum of 2 quarters · filed 2026-03-02 | $5.11M derived: sum of 3 quarters · filed 2026-08-06 | $6.75M 10-K · filed 2026-03-02 |
| 2025-09-30 | $1.75M 10-Q · filed 2025-11-07 | $3.32M derived: sum of 2 quarters · filed 2026-08-06 | $4.96M 10-Q · filed 2025-11-07 | $6.52M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.57M 10-Q · filed 2026-08-06 | $3.21M 10-Q · filed 2026-08-06 | $4.77M derived: sum of 3 quarters · filed 2026-08-06 | $6.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.64M 10-Q · filed 2026-05-07 | $3.20M derived: sum of 2 quarters · filed 2026-05-07 | $4.84M derived: sum of 3 quarters · filed 2026-05-07 | $6.29M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $3.20M derived: sum of 2 quarters · filed 2026-03-02 | $4.65M derived: sum of 3 quarters · filed 2026-03-02 | $6.32M 10-K · filed 2026-03-02 |
| 2024-09-30 | $1.64M 10-Q · filed 2025-11-07 | $3.10M derived: sum of 2 quarters · filed 2025-11-07 | $4.76M 10-Q · filed 2025-11-07 | $7.16M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $1.46M 10-Q · filed 2025-08-08 | $3.12M 10-Q · filed 2025-08-08 | $5.52M derived: sum of 3 quarters · filed 2025-08-08 | $7.94M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $1.67M 10-Q · filed 2025-05-09 | $4.07M derived: sum of 2 quarters · filed 2025-05-09 | $6.48M derived: sum of 3 quarters · filed 2025-05-09 | $8.65M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $4.81M derived: sum of 2 quarters · filed 2025-03-07 | $6.99M derived: sum of 3 quarters · filed 2025-03-07 | $9.33M 10-K · filed 2025-03-07 |
| 2023-09-30 | $2.41M 10-Q · filed 2024-11-08 | $4.59M derived: sum of 2 quarters · filed 2024-11-08 | $6.93M 10-Q · filed 2024-11-08 | $9.49M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $2.17M 10-Q · filed 2024-08-13 | $4.52M 10-Q · filed 2024-08-13 | $7.08M derived: sum of 3 quarters · filed 2024-08-13 | $9.47M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $2.34M 10-Q · filed 2024-05-13 | $4.90M derived: sum of 2 quarters · filed 2024-05-13 | $7.30M derived: sum of 3 quarters · filed 2024-05-13 | $9.90M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $4.96M derived: sum of 2 quarters · filed 2024-03-27 | $7.55M derived: sum of 3 quarters · filed 2024-03-27 | $9.15M 10-K · filed 2024-03-27 |
| 2022-09-30 | $2.40M 10-Q · filed 2023-11-13 | $5.00M derived: sum of 2 quarters · filed 2023-11-13 | $6.59M 10-Q · filed 2023-11-13 | $7.88M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $2.60M 10-Q · filed 2023-08-11 | $4.20M 10-Q · filed 2023-08-11 | $5.48M derived: sum of 3 quarters · filed 2023-08-11 | $6.36M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $1.60M 10-Q · filed 2023-05-11 | $2.88M derived: sum of 2 quarters · filed 2023-05-11 | $3.77M derived: sum of 3 quarters · filed 2023-05-11 | $4.67M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $2.17M derived: sum of 2 quarters · filed 2023-03-30 | $3.07M derived: sum of 3 quarters · filed 2023-03-30 | $3.78M 10-K · filed 2023-03-30 |
| 2021-09-30 | $885.00K 10-Q · filed 2022-11-14 | $1.79M derived: sum of 2 quarters · filed 2022-11-14 | $2.49M 10-Q · filed 2022-11-14 | $3.33M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $904.00K 10-Q · filed 2022-08-11 | $1.61M 10-Q · filed 2022-08-11 | $2.45M derived: sum of 3 quarters · filed 2022-08-11 | $3.01M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $705.00K 10-Q · filed 2022-05-12 | $1.54M derived: sum of 2 quarters · filed 2022-05-12 | $2.10M derived: sum of 3 quarters · filed 2022-05-12 | $2.58M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $840.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $1.40M derived: sum of 2 quarters · filed 2022-03-18 | $1.88M derived: sum of 3 quarters · filed 2022-03-18 | $2.23M 10-K · filed 2022-03-18 |
| 2020-09-30 | $558.00K 10-Q · filed 2021-11-12 | $1.04M derived: sum of 2 quarters · filed 2021-11-12 | $1.39M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $481.00K 10-Q · filed 2021-08-13 | $831.00K 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |